New Read & Publish Open Access agreement between The Company of Biologists and the IISER Consortium India

The Company of Biologists is delighted to announce a new Read & Publish Open Access agreement with the IISER Consortium for 2023.

Corresponding authors at participating IISER institutions in India can publish an uncapped number of research articles immediately Open Access (OA) in our hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology) plus our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC). Researchers at participating institutions also benefit from unlimited access to our hybrid journals, including their full archives dating back to 1853.

Dr P Visakhi for IISER – Mohali, Dr Umeshareddy Kacherki for IISER – Pune and Mr K Murugaraj for IISER Tirupati say:

“We are delighted with the new Read & Publish agreement between The Company of Biologists and the IISER Library Consortium. Researchers at participating institutions will benefit from the ability to publish an unlimited number of Open Access articles in all five journals. This mutually agreed arrangement is expected to yield excellent results within the Open Science landscape.”

Sarah Logan, Regional Sales Manager at The Company of Biologists, says:

“We are very excited about our first Read & Publish consortium partnership in India with the IISER Consortium. We have a long-established relationship for subscriptions with the IISER consortium and are pleased to see members embrace this transition to Open Access publishing. These new agreements come at a time of emergent interest in our Read & Publish model, and we are delighted to see IISER members from PuneMohali and Tirupati at the forefront of this transition.”

Claire Moulton, Publisher at The Company of Biologists, says:

“As a not-for-profit publisher dedicated to supporting the biological community worldwide, we have a long-standing commitment to Open Access publishing. Our journals were the first in the world to be awarded Transformative Journal status by Plan S and the success of our Read & Publish initiative has already driven a significant increase in Open Access research content in our hybrid journals. We welcome our new Read & Publish agreement with the IISER Consortium and look forward to working together to promote the growth of Open Access publishing in the biological and biomedical sciences in India.”